Literature DB >> 17036564

Answers to frequently asked questions about migraine.

Ivan Garza1, Jerry W Swanson.   

Abstract

Migraine is a common primary headache disorder associated with pronounced disability and hence marked economic and public health Implications. Appropriate treatment is warranted to limit the associated disability migraineurs experience. Because of the heterogeneity of migraine, treatment plans must be individualized. The purpose of this article is to provide answers to frequently asked questions regarding the management of migraine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036564     DOI: 10.4065/81.10.1387

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  2 in total

1.  An oral calcitonin gene-related peptide receptor antagonist for acute migraine management: sign of a possible new chapter in headache medicine.

Authors:  Ivan Garza
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

2.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.